Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Safflower (Carthamus tinctorius) extract helps hair grow and could be used in hair products.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Higher BMI links to worse hair loss in Taiwanese men.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Researchers created LabeledIn, a detailed list of drug uses, showing the importance of human input in making such lists.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Female hair loss linked to metabolic syndrome, not in males.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Some herbs show promise as antiandrogenic agents.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Men can report their own balding patterns well enough for large health studies.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.